The review proposes a three-step translational framework—patient stratification, target constraint, and cargo matching—and delineates five interlinked clinical development barriers: long-term safety of repeated BBB opening, technical standardization and reproducibility, quantifiable intracerebral PK, biological hit verification, and mechanism-enriched trial design.
Chungang Zhang, Deyu Fang, Lin Zhang· Drug Design, Development and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.